The American Psychological Association voiced serious concern regarding the bill to repeal and replace the Affordable Care Act, arguing that it would reduce mental health and substance use coverage for millions of Americans enrolled in Medicaid and contribute to the loss of coverage for millions more individuals.
American College of Rheumatology President Sharad Lakhanpal, MBBS, MD, released a statement this morning expressing concern about the American Health Care Act's (AHCA) age-based tax credits and its failure to repeal the Independent Payment Advisory Board.
Several public health insurance programs and mandates that were protected or extended by the ACA, including Medicaid, the Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA), and the Individuals with Disabilities Education Act (IDEA), are now at risk of being negatively altered or removed, posing a serious threat to the health and well-being of children and adults with disabilities according to a new perspective paper published by researchers in the Perelman School of Medicine and the Johns Hopkins Bloomberg School of Public Health.
The most recent global cancer data from the WHO highlights the growing differences in mortality rate among regions of the world bearing very different economic circumstances.
Congressman Doug Collins (R-GA) Prescription Drug Price Transparency Act (H.R. 1316) will introduce greater transparency and accountability from pharmacy benefit managers (PBMs), lower costs for patients and taxpayers
The International Association of Mutual Benefit Societies (AIM) wrote to EU health ministers on Friday to urge them to take "proper action" on endocrine disrupting chemicals (EDCs).
The Society for Risk Analysis (SRA) invites submission of abstracts for presentations at the 2017 SRA Annual Meeting to be held at the Crystal Gateway Marriott in Arlington, Virginia from Dec. 10-14, 2017.
Dr. Chaudhry (FSMB President and CEO) sits down with Dr. Daniel Gifford, Immediate Past Chairman of the FSMB Board of Directors and Chair of the Workgroup on FSMB’s Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain. Drs. Chaudhry and Gifford discuss the work of FSMB's Workgroups as they prepare for the future of medical regulation and assisting state medical boards in their mission to protect the public.
In a landmark Court victory, Ryan King won the right to direct his own life, with the support of his family, finally free after 15 years under a guardianship he never needed.
The American Thyroid Association (ATA) calls upon our country’s leadership to lift the travel restriction so that we may continue to bring all relevant scientific and clinical advances before the thyroid community. The diversity our organization enjoys greatly enhances the knowledge base of thyroid disease for all involved in our activities, who in turn translate that knowledge to improved care for all persons around the world.
The public’s wariness with new technologies, like CRISPR-9 and gene editing, is largely based on ethical, religious and social concerns, rather than concerns about safety or efficacy, which is what regulatory agencies are limited to consider.
The Endocrine Society expressed disappointment today in the European Commission's revised proposal on defining and identifying endocrine-disrupting chemicals (EDCs), citing unnecessarily narrow criteria for identifying EDCs that will make it nearly impossible for regulatory agencies to meet the unrealistically high burden of proof and protect the public from dangerous chemicals.
Northwestern University has joined with 16 other leading research universities to file an amicus brief with the U.S. District Court for the Eastern District of New York in a lawsuit opposing the executive order on immigration issued recently by President Donald Trump.
Considered as a whole, one finding stood out that may prompt institutions to reflect on their priorities. That finding: “Good teaching is the primary means through which institutions affect students.”
The Community Oncology Alliance (COA) believes that Dr. Tom Price’s perspective as the first physician to be Secretary of HHS in over two decades, will bring an important firsthand understanding of the challenges that America’s physicians face and the impact Federal policymaking has on patient care.
It’s time for the Medicare system to take non-medical, “social” risk factors into account when it decides how to pay or grade hospitals and other health care providers, two experts say based on a new National Academies report. Doing so could incentivize better care for all patients.
AACN applauds the introduction of the Title VIII Nursing Workforce Reauthorization Act of 2017 by Representatives David Joyce (R-OH), Tulsi Gabbard (D-HI), Doris Matsui (D-CA), Rodney Davis (R-IL), Suzanne Bonamici (D-OR), Patrick Meehan (R-PA), and Kathy Castor (D-FL). For over 50 years, Title VIII programs have helped provide a direct response to the call for nursing services across America. This legislation would reauthorize the Nursing Workforce Development Programs (Title VIII of the Public Health Service Act) through Fiscal Year 2022 and aligns them with current trends in the profession.
The American Society for Cell Biology has re-issued a position paper on ways to modernize immigration policy to foster scientific collaboration across borders.
As the new Congress and administration wrestle with policy decisions on the provision of high quality, affordable health coverage, the American Society for Radiation Oncology (ASTRO) urges policymakers to prioritize reforms that avoid disruption in coverage and care.
While safeguarding the nation from terrorist entry is of critical national importance, the Trump administration’s proposed restrictions on refugees and other visitors are likely to compound the stress and trauma already experienced by populations at risk for discrimination, limit scientific progress and increase stigma, according to the American Psychological Association.